ChemoCentryx
CCXI
#3706
Rank
C$5.19 B
Marketcap
C$72.25
Share price
0.00%
Change (1 day)
35.48%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): C-$2.40

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is C-$2.63. In 2021 the company made an earnings per share (EPS) of C-$2.63 a decrease over its 2020 EPS that were of C-$1.13.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)C-$2.40-8.66%
2021C-$2.63133.33%
2020C-$1.13-16.49%
2019C-$1.3527.63%
2018C-$1.06-305.41%
2017C$0.51-142.53%
2016C-$1.21-19.44%
2015C-$1.50-0%
2014C-$1.5013.68%
2013C-$1.32-16.67%
2012C-$1.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.14-562.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.82-169.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.86-208.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.12-866.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$12.99-594.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.94-288.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.95-288.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.40-305.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.90-172.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel